Enzalutamide added to salvage radiotherapy tied to better PFS in high-risk BCR
Retrospective · Urology Times · 2026-09-29. Number 5 in the UrologyWatch Top 5 for September 30, 2026.
A study reports that adding enzalutamide to salvage radiotherapy is associated with improved progression-free survival in patients with high-risk biochemical recurrence after prostatectomy.
Why it matters: Suggests a potential treatment intensification strategy for high-risk BCR patients undergoing salvage radiation.
Source: Urology Times · PubMed 36367998 · DOI 10.1200/jco.22.01662
Loading today's edition…